These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study Group. Wolters EC; Horstink MW; Roos RA; Jansen EN Adv Neurol; 1993; 60():648-52. PubMed ID: 8420204 [No Abstract] [Full Text] [Related]
5. Sinemet CR in Parkinson's disease. Pfeiffer RF; Wilken KE; Glaeske CS; Hofman R Nebr Med J; 1991 Jan; 76(1):8-10. PubMed ID: 1997878 [TBL] [Abstract][Full Text] [Related]
7. Treatment of early Parkinson's disease with controlled-release levodopa preparations. Rinne UK; Rinne JO Neurology; 1989 Nov; 39(11 Suppl 2):78-81; discussion 95. PubMed ID: 2586766 [TBL] [Abstract][Full Text] [Related]
8. Double-blind comparison of standard Sinemet and Sinemet CR in patients with mild-to-moderate Parkinson's disease. Feldman RG; Mosbach PA; Kelly MR; Thomas CA; Saint Hilaire MH Neurology; 1989 Nov; 39(11 Suppl 2):96-101; discussion 105. PubMed ID: 2685655 [TBL] [Abstract][Full Text] [Related]
9. Controlled-release carbidopa/levodopa (CR) in parkinsonian patients with response fluctuations on standard levodopa treatment: clinical and pharmacokinetic observations. Deleu D; Jacques M; Michotte Y; Ebinger G Neurology; 1989 Nov; 39(11 Suppl 2):88-92; discussion 95. PubMed ID: 2685654 [TBL] [Abstract][Full Text] [Related]
10. Plasma levels of levodopa and its main metabolites in parkinsonian patients after conventional and controlled-release levodopa-carbidopa associations. Benetello P; Furlanut M; Zara G; Baraldo M; Hassan E Eur Neurol; 1993; 33(1):69-73. PubMed ID: 8440292 [TBL] [Abstract][Full Text] [Related]
11. Experiences with Sinemet CR in the Paracelsus-Elena-Klinik. Ulm G; Gerdes U; Haagen K Neurology; 1989 Nov; 39(11 Suppl 2):85-7; discussion 95. PubMed ID: 2586768 [TBL] [Abstract][Full Text] [Related]
12. [The use of the Sinemet-CR preparation in treating Parkinson's disease]. Artem'ev DV; Damulin IV; Iakhno NN Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(5):31-5. PubMed ID: 8585372 [TBL] [Abstract][Full Text] [Related]
13. Development and progression of motor fluctuations and side effects in Parkinson's disease: comparison of Sinemet CR versus carbidopa/levodopa. Goetz CG; Tanner CM; Gilley DW; Klawans HL Neurology; 1989 Nov; 39(11 Suppl 2):63-6; discussion 72-3. PubMed ID: 2586764 [TBL] [Abstract][Full Text] [Related]
14. An open multicenter long-term treatment evaluation of Sinemet CR. Sinemet CR Multicenter Study Group. Bush DF; Liss CL; Morton A Neurology; 1989 Nov; 39(11 Suppl 2):101-4; discussion 105. PubMed ID: 2685646 [TBL] [Abstract][Full Text] [Related]
15. Comparison of controlled-release Sinemet (CR4) and standard Sinemet (25 mg/100 mg) in advanced Parkinson's disease: a double-blind, crossover study. Sage JI; Mark MH Clin Neuropharmacol; 1988 Apr; 11(2):174-9. PubMed ID: 3378226 [No Abstract] [Full Text] [Related]
16. Effect of controlled-release carbidopa/levodopa on motor performance in advanced Parkinson's disease. Rondot P; Ziegler M; Aymard N; Teinturier A Neurology; 1989 Nov; 39(11 Suppl 2):74-7; discussion 95. PubMed ID: 2586765 [TBL] [Abstract][Full Text] [Related]
17. Sinemet in Parkinson's disease: efficacy with and without food. Bozek CB; Suchowersky O; Purves S; Calne S; Calne DB Clin Neuropharmacol; 1986; 9(2):196-9. PubMed ID: 3708604 [No Abstract] [Full Text] [Related]
18. The influence of a standard meal on Sinemet CR absorption in patients with Parkinson's disease. Roos RA; Tijssen MA; van der Velde EA; Breimer DD Clin Neurol Neurosurg; 1993 Sep; 95(3):215-9. PubMed ID: 8242964 [TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of Sinemet CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open, and a double-blind, double-dummy, multicenter treatment evaluation. The Dutch Sinemet CR Study Group. Wolters EC; Horstink MW; Roos RA; Jansen EN Clin Neurol Neurosurg; 1992; 94(3):205-11. PubMed ID: 1327609 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies. Yeh KC; August TF; Bush DF; Lasseter KC; Musson DG; Schwartz S; Smith ME; Titus DC Neurology; 1989 Nov; 39(11 Suppl 2):25-38. PubMed ID: 2685649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]